Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Medical Oncology
•
Cancer of Unknown Primary
How would you manage a non-smoking, premenopausal female patient with a large retroperitoneal squamous cell carcinoma with local adenopathy, without other distant metastatic disease?
Related Questions
Can you use NGS panels or ctDNA to help you find organ of origin in the workup of carcinoma of unknown origin?
How does the presence of PSMA negative lesions in a patient with mCRPC affect your decision to treat with Lutetium (177Lu) vipivotide tetraxetan?
How would you approach a patient with limited stage SCLC who progressed immediately after completing chemoradiation with brain metastasis?
How would you manage a patient with mCRPC with a good clinical and >50% reduction in PSA to Lu-PSMA but evidence of radiographic progression on PSMA PET/CT?
How would you treat rapidly growing inflammatory breast cancer, invasive lobular triple negative subtype, after two cycles of neoadjuvant keynote 522?
When do you consider indefinite anticoagulation in someone with first episode of calf vein DVT?
How do you employ focal therapies in localized hepatocellular carcinoma?
What is your approach to mitigating the infection risk with bispecific antibodies in multiple myeloma?
Is bilateral hearing loss requiring hearing aids an absolute or relative contraindication for neoadjuvant cisplatin in MIBC?
Do you think it's appropriate to run separate NGS panels on biopsies from lesions in both the right and left lung in a patient suspected of two lung primaries?